Paradigm Biocapital Advisors’s TScan Therapeutics TCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-353,886	Closed	-$2.07M	–	38
2024 Q2	$2.07M	Buy	+353,886	New	+$2.07M	0.08%	35